2025-08-08 19:59:08
Latest Post
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
RBI grants NBFC license to Equirus Group
Stock Report
AMS Polymers Q3FY22 PAT at Rs. 2.13 lakhs
Posted On : 2022-02-04 15:20:02( TIMEZONE : IST )
has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 15.9179 crores during the period ended December 31, 2021 as compared to Rs. 11.9539 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.0213 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. .0297 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.06 for the period ended December 31, 2021 as compared to Rs. 0.09 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 15.9179 crs | ₹11.9539 crs |  33.16% |
| Net Profit | ₹0.0213 crs | ₹.0297 crs |  -28.28% |
| EPS | ₹0.06 | ₹0.09 | -33.33% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 15.9179 crores during the period ended December 31, 2021 as compared to Rs.9.4381 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.0213 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.1348 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.06 for the period ended December 31, 2021 as compared to Rs.0.41 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 15.9179 crs | ₹9.4381 crs | 68.66% |
| Net Profit | ₹0.0213 crs | ₹0.1348 crs | -84.20% |
| EPS | ₹0.06 | ₹0.41 | -85.37% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.35.9262 crores during the 9 Months period ended December 31, 2021 as compared to Rs.22.5997 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.0751 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.1529 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.0.23 for the 9 Months period ended December 31, 2021 as compared to Rs.0.46 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹35.9262 crs | ₹22.5997 crs | 58.97% |
| Net Profit | ₹0.0751 crs | ₹0.1529 crs | -50.88% |
| EPS | ₹0.23 | ₹0.46 | -50.00% |
